Alk-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) Progressed on or Intolerant to Crizotinib
Medical Indication
Total Brands
2
Generics
1
Total Brands
2
Generics
1
Available Brands (2)
Found 2 results
Filter by A-Z
| Brand Name | Generic Name | Form & Strength | Company | Unit Price |
|---|---|---|---|---|
| Alecensa 150mg | Alectinib | 150mg | Capsule | Roche Bangladesh Limited | ৳ 1015.05 |
| Alecnib 150mg | Alectinib | 150mg | Capsule | Everest Pharmaceuticals Ltd. | ৳ 500.00 |
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.